Rigel Pharmaceuticals
RIGL
$1.10
Share price
0.00%
Change (1 day)
-1.79%
Change (1 year)
Categories
EPS for Rigel Pharmaceuticals (RIGL)
EPS in 2023 (TTM): -$0.22
According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.22. In 2022 the company made an earnings per share (EPS) of -$0.34 a decrease over its 2021 EPS that were of -$0.10000.
EPS history for Rigel Pharmaceuticals from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.22 | -35.29% |
| 2022 | -$0.34 | 240% |
| 2021 | -$0.10000 | -37.5% |
| 2020 | -$0.16 | -60% |
| 2019 | -$0.40 | -11.11% |
| 2018 | -$0.45 | -26.23% |
| 2017 | -$0.61 | -17.57% |
| 2016 | -$0.74 | 25.42% |
| 2015 | -$0.59 | -42.72% |
| 2014 | -$1.03 | 1.98% |
| 2013 | -$1.01 | -24.06% |
| 2012 | -$1.33 | -4.32% |
| 2011 | -$1.39 | -290.41% |
| 2010 | $0.73 | -126.64% |
| 2009 | -$2.74 | -25.14% |
| 2008 | -$3.66 | 41.86% |
| 2007 | -$2.58 | 70.86% |
| 2006 | -$1.51 | -27.4% |
| 2005 | -$2.08 | -33.33% |
| 2004 | -$3.12 | -37.73% |
| 2003 | -$5.01 | -31.83% |
| 2002 | -$7.35 | -63.55% |
| 2001 | -$20.16 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $14.15 | -6,531.82% | 🇺🇸 USA |
 AstraZeneca AZN | $1.98 | -1,002.27% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | -$1.44 | 554.55% | 🇺🇸 USA |
 ChemoCentryx CCXI | -$1.89 | 759.09% | 🇺🇸 USA |